Bayer HealthCare is facing a new Essure lawsuit filed by over a dozen claimants, alleging the permanent contraceptive caused them serious injuries.

This Essure lawsuit was filed after these women say they discovered the similar nature of their injuries, and that they all relied on the marketing statements and product information provided by Bayer Healthcare.

According to the Essure lawsuit, the claimants were never warned that the device’s coils can migrate out of the fallopian tubes and cause severe complications. Often, alleges the lawsuit, surgery was required and that put the claimants at further risk for serious injury.

The claimants allege that they were not warned that the Essure contraceptive had a higher failure rate compared to alternative treatment options.

The Essure birth control device consists of two nickel alloy coils that are each implanted into each of the fallopian tubes. The metal coils eventually spur growth of scar tissue that eventually blocks sperm to egg fertilization.

The Essure was well known for being the only non surgical female sterilization method in the United States, and quickly became popular for its convenience and minimally invasive implant procedure.

However, almost 10,00 Essure injury reports have been submitted since the product since 2002, with Bayer set to take the device off the market in 2019.

Overview of Essure Lawsuit Allegations

Even though potential Essure complications are well known now, the claimants involved in the Essure lawsuit says they were not aware of these problems at the time they were recommended the product. The claimants who filed this Essure lawsuit include:

• Plaintiff Regina P. who says she had the Essure birth control coils implanted in June 2010, but reportedly began experiencing severe pelvic and abdominal pain, severe cramping, heavy bleeding, and other complications. Regina alleges she learned that these side effects may have been linked to the Essure in March 2018, when she learned other women had suffered similar side effects and that the FDA was investigating the complaints.
• Plaintiff Yvette V. who alleges she had the Essure birth control coils implanted in May 2015, but started experiencing severe pelvic and abdominal pain, severe cramping, heavy bleeding, and other painful complications. Yvette says she discovered the defective nature of the Essure birth control device, after learning other women suffered complications and that the FDA was investigating the claims.
• Plaintiff Tywila U. says she had the Essure birth control coils implanted in July 2003, and soon started experiencing severe abdominal and pelvic pain, abnormal bleeding, and other complications. These side effects allegedly forced Tywila had undergone one or more surgeries to remove one or more the coils on Sept. 4, 2003. Similar to the other women in the Essure lawsuit, Tywila says she discovered the allegedly defective nature of the permanent contraceptive after learning that numerous other women suffered these complications and that the FDA was conducting an investigation.

For each of these women, alleges the Essure lawsuit, the potential for severe complications was not disclosed, depriving them of the ability to make an informed decision.

Each of these women contends that she would not have agreed to have the Essure coils implanted if they had known about the severity of the potential device complications.

This Essure Lawsuit is Case No. 18CECG03845, Superior Court of the State of California County of Fresno- Unlimited Jurisdiction.